Internal Medicine · Flushuing, NY
NPI
1063401644
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
131-72 40th Rd
Flushuing, NY, 11354
Phone (718) 587-1111
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$483K
5,420 prescriptions
Company payments, 2025
$543
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Shuyi Wu prescribed most often to Medicare patients was Atorvastatin Calcium, with 487 prescriptions and refills. In total Shuyi Wu wrote 5,420 Medicare prescriptions that cost $483K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 487 | 771 | 76 | $3,091 |
| Losartan Potassium Generic | 459 | 757 | 71 | $2,789 |
| Amlodipine Besylate Generic | 360 | 590 | 59 | $1,916 |
| Simvastatin Generic | 308 | 525 | 49 | $1,858 |
| Vascepa Icosapent Ethyl | 267 | 428 | 47 | $142K |
| Rosuvastatin Calcium Generic | 247 | 371 | 40 | $1,462 |
| Metoprolol Succinate Generic | 235 | 347 | 36 | $1,533 |
| Alendronate Sodium Generic | 232 | 420 | 45 | $1,324 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 223 | 346 | 37 | $1,908 |
| Tamsulosin Hcl Generic | 149 | 239 | 25 | $1,376 |
| Metformin Hcl Generic | 143 | 247 | 26 | $810 |
| Finasteride Generic | 127 | 187 | 22 | $716 |
| Omeprazole Generic | 123 | 137 | 36 | $928 |
| Metformin Hcl Er Metformin Hcl | 80 | 146 | 14 | $351 |
| Fluticasone Propionate Generic | 74 | 119 | 25 | $818 |
Brand drugs: 727 claims; generic drugs: 4,623 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shuyi Wu $543 ($543 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.